Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
Sales | 1 | 3 | 28 | 45 | 91 |
Gross Profit | 1 | 3 | 28 | 45 | 91 |
Operating Expenses | 8,889 | 6,758 | 5,884 | 6,624 | 6,164 |
Operating Income | -8,888 | -6,755 | -5,856 | -6,579 | -6,073 |
Pre-tax Income | -8,888 | -6,755 | -5,856 | -6,579 | -6,073 |
Net Income Continuous | -8,888 | -6,755 | -5,856 | -6,579 | -6,073 |
Net Income | $-8,888 | $-6,755 | $-5,856 | $-6,579 | $-6,073 |
EPS Basic Total Ops | -2.36 | -1.80 | -1.50 | -2.04 | -1.92 |
EPS Basic Continuous Ops | -2.34 | -1.78 | -1.48 | -2.06 | -1.90 |
EPS Diluted Total Ops | -2.36 | -1.80 | -1.50 | -2.04 | -1.92 |
EPS Diluted Continuous Ops | -2.34 | -1.78 | -1.48 | -2.06 | -1.90 |
EBITDA(a) | $-8,871 | $-6,738 | $-5,838 | $-6,567 | $-6,062 |